Status:
COMPLETED
Naturalistic Monitoring and Treatment of Chronic Insomnia
Lead Sponsor:
Washington State University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Chronic Insomnia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
90 individuals with chronic insomniacs and 30 healthy normal sleepers will have their sleep monitored by the SleepScore Max for 10 weeks. Individuals with chronic insomnia will be randomized into one ...
Detailed Description
90 chronic insomniacs, carefully screened using the criteria of Chronic Insomnia Disorder according to the International Classification of Sleep Disorders 3 (ICSD-3), will be studied. Additionally, 30...
Eligibility Criteria
Inclusion
- Age 18-65
- Physically and psychologically healthy (except for chronic insomnia for the insomnia participants) as assessed by questionnaires and history
- No sleep disorders other than chronic insomnia (for insomnia participants only) as assessed by questionnaires and history
- Has daily access to an iPhone
Exclusion
- Non-English speaking
Key Trial Info
Start Date :
January 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04013321
Start Date
January 23 2020
End Date
October 10 2021
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sleep and Performance Research Center
Spokane, Washington, United States, 99202